Portfolio company
Digma Medical
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops endoscopic laser ablation platforms for gastrointestinal diseases and metabolic conditions for hospitals and specialist medical providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Endogenex
This company develops an endoscopic system using pulsed electric fields to treat type 2 diabetes by regenerating signalling cells in the small intestine.
EXIMO
This company develops hybrid catheter technology for tissue resection in vascular and gastrointestinal endoluminal applications for healthcare providers.
CREO Medical
This company develops and manufactures minimally invasive electrosurgical devices using radiofrequency and microwave energy for healthcare professionals to treat gastrointestinal and pulmonary conditions.
HEPTA Medical
This company develops a microwave ablation platform with integrated temperature sensors for clinicians to treat early-stage lung cancer patients using minimally invasive procedures.
Prothea
This company develops integrated microendoscope and laser ablation systems for the diagnosis and treatment of lung cancer in a single hospital visit.
Ablatus Therapeutics
This company develops a bimodal electric tissue ablation medical device to treat tumours and uterine fibroids for surgical patients.
BLEED DETECTION SYSTEM
This company develops an ingestible sensor capsule and receiver to detect upper gastrointestinal bleeding for healthcare providers treating adult patients.
Advanced computer-aided gastrointestinal diagnosis
This company develops artificial intelligence software for upper gastrointestinal endoscopy to assist endoscopists in procedural monitoring and landmark visualization.
